Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
Competitive binding assays with monoclonal antibodies have been used to show that there are a minimum of three nonoverlapping antigenic sites on the G1 glycoprotein of La Crosse virus. One of these sites contains the epitopes for three of the five monoclonal antibodies employed and is involved with both hemagglutination and neutralization. A second site contains the epitope for an antibody that inhibits hemagglutination but has no neutralizing activity. The third site encompasses the epitope for an antibody that at present has no identified biological role.
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral / Q000032:analysis*; D001667:Binding, Competitive; D002043:Bunyaviridae / Q000276:immunology*; D002141:Encephalitis Virus, California / Q000276:immunology*; D000939:Epitopes / Q000032:analysis; D006387:Hemagglutination, Viral; D008562:Membrane Glycoproteins; D009500:Neutralization Tests; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D000939:Epitopes; C028391:G protein, vesicular stomatitis virus; D008562:Membrane Glycoproteins; D014759:Viral Envelope Proteins; D014764:Viral Proteins